These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38824261)

  • 1. Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis.
    Dentici ML; Niceta M; Lepri FR; Mancini C; Priolo M; Bonnard AA; Cappelletti C; Leoni C; Ciolfi A; Pizzi S; Cordeddu V; Rossi C; Ferilli M; Mucciolo M; Colona VL; Fauth C; Bellini M; Biasucci G; Sinibaldi L; Briuglia S; Gazzin A; Carli D; Memo L; Trevisson E; Schiavariello C; Luca M; Novelli A; Michot C; Sweertvaegher A; Germanaud D; Scarano E; De Luca A; Zampino G; Zenker M; Mussa A; Dallapiccola B; Cavé H; Digilio MC; Tartaglia M
    Eur J Hum Genet; 2024 Jun; ():. PubMed ID: 38824261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noonan syndrome-like phenotype associated with an ERF frameshift variant.
    Hirano Y; Kuroda Y; Enomoto Y; Naruto T; Muroya K; Kurosawa K
    Am J Med Genet A; 2024 May; ():e63652. PubMed ID: 38741564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noonan syndrome-like phenotype in a patient with heterozygous ERF truncating variant.
    Yamada M; Funato M; Kondo G; Suzuki H; Uehara T; Takenouchi T; Sakamoto Y; Kosaki K
    Congenit Anom (Kyoto); 2021 Nov; 61(6):226-230. PubMed ID: 34184330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of
    Singh R; Cohen ASA; Poulton C; Hjortshøj TD; Akahira-Azuma M; Mendiratta G; Khan WA; Azmanov DN; Woodward KJ; Kirchhoff M; Shi L; Edelmann L; Baynam G; Scott SA; Jabs EW
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERF-related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndrome.
    Glass GE; O'Hara J; Canham N; Cilliers D; Dunaway D; Fenwick AL; Jeelani NO; Johnson D; Lester T; Lord H; Morton JEV; Nishikawa H; Noons P; Schwiebert K; Shipster C; Taylor-Beadling A; Twigg SRF; Vasudevan P; Wall SA; Wilkie AOM; Wilson LC
    Am J Med Genet A; 2019 Apr; 179(4):615-627. PubMed ID: 30758909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous mutations in ERF cause syndromic craniosynostosis with multiple suture involvement.
    Chaudhry A; Sabatini P; Han L; Ray PN; Forrest C; Bowdin S
    Am J Med Genet A; 2015 Nov; 167A(11):2544-7. PubMed ID: 26097063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature.
    Addissie YA; Kotecha U; Hart RA; Martinez AF; Kruszka P; Muenke M
    Am J Med Genet A; 2015 Nov; 167A(11):2657-63. PubMed ID: 26249544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways.
    Takenouchi T; Sakamoto Y; Miwa T; Torii C; Kosaki R; Kishi K; Takahashi T; Kosaki K
    Am J Med Genet A; 2014 Nov; 164A(11):2869-72. PubMed ID: 25123707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the
    Balasubramanian M; Lord H; Levesque S; Guturu H; Thuriot F; Sillon G; Wenger AM; Sureka DL; Lester T; Johnson DS; Bowen J; Calhoun AR; Viskochil DH; ; Bejerano G; Bernstein JA; Chitayat D
    J Med Genet; 2017 Mar; 54(3):157-165. PubMed ID: 27738187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
    Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
    Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An infant with premature closure of cranial sutures due to variant of ERF gene and a literature review].
    Wang J; Wang D; Zeng L; Wang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):1009-1014. PubMed ID: 37532503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
    Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
    Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.
    Papadopoulos G; Papadopoulou A; Kosma K; Papadimitriou A; Papaevangelou V; Kanaka-Gantenbein C; Bountouvi E; Kitsiou-Tzeli S
    Eur J Pediatr; 2022 Oct; 181(10):3691-3700. PubMed ID: 35904599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
    Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
    Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of SOS2 are a rare cause of Noonan syndrome with particular predisposition for lymphatic complications.
    Lissewski C; Chune V; Pantaleoni F; De Luca A; Capri Y; Brinkmann J; Lepri F; Daniele P; Leenders E; Mazzanti L; Scarano E; Radio FC; Kutsche K; Kuechler A; Gérard M; Ranguin K; Legendre M; Vial Y; van der Burgt I; Rinne T; Andreucci E; Mastromoro G; Digilio MC; Cave H; Tartaglia M; Zenker M
    Eur J Hum Genet; 2021 Jan; 29(1):51-60. PubMed ID: 32788663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Erf-Mediated Craniosynostosis and Pharmacological Amelioration.
    Vogiatzi A; Keklikoglou K; Makris K; Argyrou DS; Zacharopoulos A; Sotiropoulou V; Parthenios N; Gkikas A; Kokkori M; Richardson MSW; Fenwick AL; Archontidi S; Arvanitidis C; Robertson J; Parthenios J; Zacharakis G; Twigg SRF; Wilkie AOM; Mavrothalassitis G
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal and infantile diagnosis of craniosynostosis in individuals with RASopathies.
    Serbinski CR; Vanderwal A; Chadwell SE; Sanchez AI; Hopkin RJ; Hufnagel RB; Weaver KN; Prada CE
    Am J Med Genet A; 2024 Feb; 194(2):195-202. PubMed ID: 37774117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrafamilial variability in six family members with ERF-related craniosynostosis syndrome type 4.
    Moddemann MK; Kieslich M; Koenig R
    Am J Med Genet A; 2022 Oct; 188(10):2969-2975. PubMed ID: 35852485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RRAS2 pathogenic variant p.Q72L produces severe Noonan syndrome with hydrocephalus: A case report.
    Weinstock NI; Sadler L
    Am J Med Genet A; 2022 Jan; 188(1):364-368. PubMed ID: 34648682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.